225 related articles for article (PubMed ID: 20508255)
1. Identification of translational activators of glial glutamate transporter EAAT2 through cell-based high-throughput screening: an approach to prevent excitotoxicity.
Colton CK; Kong Q; Lai L; Zhu MX; Seyb KI; Cuny GD; Xian J; Glicksman MA; Lin CL
J Biomol Screen; 2010 Jul; 15(6):653-62. PubMed ID: 20508255
[TBL] [Abstract][Full Text] [Related]
2. Translational control of glial glutamate transporter EAAT2 expression.
Tian G; Lai L; Guo H; Lin Y; Butchbach ME; Chang Y; Lin CL
J Biol Chem; 2007 Jan; 282(3):1727-37. PubMed ID: 17138558
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection.
Kong Q; Chang LC; Takahashi K; Liu Q; Schulte DA; Lai L; Ibabao B; Lin Y; Stouffer N; Das Mukhopadhyay C; Xing X; Seyb KI; Cuny GD; Glicksman MA; Lin CL
J Clin Invest; 2014 Mar; 124(3):1255-67. PubMed ID: 24569372
[TBL] [Abstract][Full Text] [Related]
4. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics.
Kim K; Lee SG; Kegelman TP; Su ZZ; Das SK; Dash R; Dasgupta S; Barral PM; Hedvat M; Diaz P; Reed JC; Stebbins JL; Pellecchia M; Sarkar D; Fisher PB
J Cell Physiol; 2011 Oct; 226(10):2484-93. PubMed ID: 21792905
[TBL] [Abstract][Full Text] [Related]
5. Novel Positive Allosteric Modulators of Glutamate Transport Have Neuroprotective Properties in an in Vitro Excitotoxic Model.
Falcucci RM; Wertz R; Green JL; Meucci O; Salvino J; Fontana ACK
ACS Chem Neurosci; 2019 Aug; 10(8):3437-3453. PubMed ID: 31257852
[TBL] [Abstract][Full Text] [Related]
6. Translational enhancers of EAAT2: therapeutic implications for neurodegenerative disease.
Limpert AS; Cosford ND
J Clin Invest; 2014 Mar; 124(3):964-7. PubMed ID: 24569369
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice.
Guo H; Lai L; Butchbach ME; Stockinger MP; Shan X; Bishop GA; Lin CL
Hum Mol Genet; 2003 Oct; 12(19):2519-32. PubMed ID: 12915461
[TBL] [Abstract][Full Text] [Related]
8. Genetic dys-regulation of astrocytic glutamate transporter EAAT2 and its implications in neurological disorders and manganese toxicity.
Karki P; Smith K; Johnson J; Aschner M; Lee EY
Neurochem Res; 2015 Feb; 40(2):380-8. PubMed ID: 25064045
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes.
Lee SG; Su ZZ; Emdad L; Gupta P; Sarkar D; Borjabad A; Volsky DJ; Fisher PB
J Biol Chem; 2008 May; 283(19):13116-23. PubMed ID: 18326497
[TBL] [Abstract][Full Text] [Related]
10. Impaired glutamate uptake and EAAT2 downregulation in an enterovirus chronically infected human glial cell line.
Legay V; Deleage C; Beaulieux F; Giraudon P; Aymard M; Lina B
Eur J Neurosci; 2003 May; 17(9):1820-8. PubMed ID: 12752781
[TBL] [Abstract][Full Text] [Related]
11. The 'glial' glutamate transporter, EAAT2 (Glt-1) accounts for high affinity glutamate uptake into adult rodent nerve endings.
Suchak SK; Baloyianni NV; Perkinton MS; Williams RJ; Meldrum BS; Rattray M
J Neurochem; 2003 Feb; 84(3):522-32. PubMed ID: 12558972
[TBL] [Abstract][Full Text] [Related]
12. Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression.
Li Y; Sattler R; Yang EJ; Nunes A; Ayukawa Y; Akhtar S; Ji G; Zhang PW; Rothstein JD
Neuropharmacology; 2011 Jun; 60(7-8):1168-75. PubMed ID: 21034752
[TBL] [Abstract][Full Text] [Related]
13. Decrease in glial glutamate transporter variants and excitatory amino acid receptor down-regulation in a murine model of ALS-PDC.
Wilson JM; Khabazian I; Pow DV; Craig UK; Shaw CA
Neuromolecular Med; 2003; 3(2):105-18. PubMed ID: 12728193
[TBL] [Abstract][Full Text] [Related]
14. Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: Opportunities for novel therapeutics development.
Green JL; Dos Santos WF; Fontana ACK
Biochem Pharmacol; 2021 Nov; 193():114786. PubMed ID: 34571003
[TBL] [Abstract][Full Text] [Related]
15. Current approaches to enhance glutamate transporter function and expression.
Fontana AC
J Neurochem; 2015 Sep; 134(6):982-1007. PubMed ID: 26096891
[TBL] [Abstract][Full Text] [Related]
16. Identification of Novel Allosteric Modulators of Glutamate Transporter EAAT2.
Kortagere S; Mortensen OV; Xia J; Lester W; Fang Y; Srikanth Y; Salvino JM; Fontana ACK
ACS Chem Neurosci; 2018 Mar; 9(3):522-534. PubMed ID: 29140675
[TBL] [Abstract][Full Text] [Related]
17. Glutamate transporter EAAT2: a new target for the treatment of neurodegenerative diseases.
Lin CL; Kong Q; Cuny GD; Glicksman MA
Future Med Chem; 2012 Sep; 4(13):1689-700. PubMed ID: 22924507
[TBL] [Abstract][Full Text] [Related]
18. Sumoylation of the astroglial glutamate transporter EAAT2 governs its intracellular compartmentalization.
Foran E; Rosenblum L; Bogush A; Pasinelli P; Trotti D
Glia; 2014 Aug; 62(8):1241-53. PubMed ID: 24753081
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing of the 5'-sequences of the mouse EAAT2 glutamate transporter and expression in a transgenic model for amyotrophic lateral sclerosis.
Münch C; Ebstein M; Seefried U; Zhu B; Stamm S; Landwehrmeyer GB; Ludolph AC; Schwalenstöcker B; Meyer T
J Neurochem; 2002 Aug; 82(3):594-603. PubMed ID: 12153483
[TBL] [Abstract][Full Text] [Related]
20. Human glioma cells and undifferentiated primary astrocytes that express aberrant EAAT2 mRNA inhibit normal EAAT2 protein expression and prevent cell death.
Guo H; Lai L; Butchbach ME; Lin CL
Mol Cell Neurosci; 2002 Dec; 21(4):546-60. PubMed ID: 12504589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
